About
Mr. Holman is co-Founder and Managing Director of Genesys Capital and has extensive commercial and technical experience in the biotechnology industry. Since co-founding Genesys Capital in 2000, Mr. Holman has been actively involved in raising over $225 million of venture capital and has been instrumental in deploying over $140 million across 28 investments. He currently serves on the Board of Directors of Functional Neuromodulation Ltd. and ImpoPharma Inc. From 2001 to 2013, he served on the board of Epocal, a Genesys portfolio company recently acquired by Alere (NYSE: ALR). Mr. Holman is active in deal origination and company creation and has advised Canada's National Biotechnology Advisory Committee on strategies for financing start-up and early-stage biotechnology companies. Prior to co-founding Genesys Capital, Mr. Holman was a Senior Investment Manager with MDS Capital Corp. During his tenure at MDS, he was involved in all stages of investment from start-up and early-stage to mez
Position in the VCSift Database
- • 7 investors at Genesys Capital are tracked.
- • 1,801 investors hold the Co-Founder and Managing Director role in VCSift. Kelly Holman is one of them.
- • 2,014 investors are based in Toronto, Ontario, Canada.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Toronto, Canada
Contact Information
Find more investors like Kelly
Search Investors